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Abstract
Background: The salmon louse (Lepeophtheirus salmonis Krøyer), an ectoparasitic copepod with a complex life cycle
causes significant losses in salmon aquaculture. Pesticide treatments against the parasite raise environmental concerns
and their efficacy is gradually decreasing. Improvement of fish resistance to lice, through biological control methods,
needs better understanding of the protective mechanisms. We used a 21 k oligonucleotide microarray and RT-qPCR to
examine the time-course of immune gene expression changes in salmon skin, spleen, and head kidney during the first
15 days after challenge, which encompassed the copepod and chalimus stages of lice development.
Results: Large scale and highly complex transcriptome responses were found already one day after infection (dpi).
Many genes showed bi-phasic expression profiles with abrupt changes between 5 and 10 dpi (the copepod-
chalimus transitions); the greatest fluctuations (up- and down-regulation) were seen in a large group of secretory
splenic proteases with unknown roles. Rapid sensing was witnessed with induction of genes involved in innate
immunity including lectins and enzymes of eicosanoid metabolism in skin and acute phase proteins in spleen.
Transient (1-5 dpi) increase of T-cell receptor alpha, CD4-1, and possible regulators of lymphocyte differentiation
suggested recruitment of T-cells of unidentified lineage to the skin. After 5 dpi the magnitude of transcriptomic
responses decreased markedly in skin. Up-regulation of matrix metalloproteinases in all studied organs suggested
establishment of a chronic inflammatory status. Up-regulation of putative lymphocyte G0/G1 switch proteins in
spleen at 5 dpi, immunoglobulins at 15 dpi; and increase of IgM and IgT transcripts in skin indicated an onset of
adaptive humoral immune responses, whereas MHCI appeared to be down-regulated.
Conclusions: Atlantic salmon develops rapid local and systemic reactions to L. salmonis,w h i c h ,h o w e v e r ,d on o tr e s u l t
in substantial level of protection. The dramatic changes observed after 5 dpi can be associated with metamorphosis of
copepod, immune modulation by the parasite, or transition from innate to adaptive immune responses.
Background
The salmon louse (Lepeophtheirus salmonis Krøyer) is a
widespread disease-causing marine ectoparasitic cope-
pod infecting wild and farmed salmonids. The develop-
ment of L. salmonis encompasses ten stages: two
nauplii, a copepodid, four chalimus, two pre-adult, and
an adult stage [1]. The nauplii hatch directly from egg-
strings attached to the female lice. The two nauplii
stages and the copepodid are free-living larvae that uti-
lize yolk and other components provided maternally.
The copepodid is the infectious stage of L. salmonis;i t s
ability to settle and to recognize a relevant host is of cri-
tical importance for the parasite. We have observed that
L. salmonis copepodids use 7-11 days (at 9.3°C) before
they all have completed the molt to chalimus I. The
four chalimus stages are physically attached to the host
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lence by L. salmonis has been observed as the parasite
reaches the pre-adult stages [2], the chalimus stage can
also account for smolt mortalities (e.g. in small pink sal-
mon [3]). Lice damage fish by feeding on their mucus,
skin, and blood and the wounds increase the risk of sec-
ondary infections. At present, L. salmonis is recognized
as one of the major problems in salmon aquaculture in
Norway, UK, USA, and Canada; whereas in Chile, a
Caligus species (C. rogercresseyi) gives similar problems.
The annual global loss due to sea lice in salmonid aqua-
culture is estimated to be more than 300 million USD
[4]. Moreover, lice originating from farmed salmon may
cause infections and mortality on wild salmonids [4,5].
L. salmonis is controlled mainly by pesticides and at
present only a few types are available, emamectin benzo-
ate being the most commonly used [6]. However,
increasing concerns about development of pesticide
resistance, occurrence of treatment failures, and undesir-
able environmental impacts raise questions about the
future of this strategy. The need for new methods of
parasite control is fully recognized by the industry,
authorities and society. At this time multiple studies
assess improvement of salmon resistance to lice with an
aid of selective breeding, special feeds and immune sti-
mulants. The possibility of immunization and vaccina-
tion against L. salmonis infection is discussed [7,8].
However, protective antibody responses following
repeated challenge are weak. Better understanding of
acquired immune responses is essential for vaccine
development. However, data on factors related to adap-
tive immunity are lacking in this host-parasite system
[7,9]. Development of biological methods of protection
needs better understanding of mechanisms underlying
resistance to lice. The ability to suppress and reject
parasites shortly after infection can be associated with
innate immunity. Early innate responses are especially
important since they greatly influence the subsequent
responses that develop in the immune cascade. Such
responses are believed to explain considerable differ-
ences between the salmonid species in susceptibility to
lice [10]. Limited epithelial hyperplasia and inflamma-
tion after infection with the parasite were reported in
Atlantic salmon (Salmo salar L.) and this was in con-
trast to highly resistant coho salmon (Oncorhynchus
kisutsch) and chinook (O. nerka) salmon [11]. This can
be related to inherent constraints of the immune system
or its modulation by the parasite. In addition, Atlantic
salmon possesses thin epidermal layer, sparsely distribu-
ted mucus cells, and exhibits low mucus lysozyme and
protease activity as compared to other salmonids [12].
Knowledge of salmon immune responses to lice and
their roles in protection against parasite is still limited.
Until present, studies have addressed a relatively small
number of immune parameters. Development of high-
throughput analytical methods makes it possible to
expand the search and to monitor large number of
immune pathways in parallel at the gene expression
level. In a previous study, we used a 1.8 k cDNA micro-
array (SFA2 or immunochip) to examine the local and
systemic responses of Atlantic salmon to lice within the
whole infection period [13]. This platform included a
relatively small number of genes and the early responses
were represented with only one time-point - 3 days post
infection (dpi.). In this paper we report immune related
responses during the first 15 dpi, divided in five time-
points. This enabled us to see how the host is respond-
ing during the early infection period. In this study, we
used the Atlantic salmon oligonucleotide platform dis-
cussed in detail in [14]. Gene expression profiling was
done in skin and spleen and real-time RT-qPCR ana-
lyses were performed in these tissues, and also in the
head kidney.
Results
Lice count and a summary of gene expression changes
T h en u m b e ro fl i c ew a sd e t e r m i n e da t1 5d p i( t h el a s t
day of experiment), and high counts (58.4 ± 9.48 lice per
fish, all at chalimus I to III stage) from 100 copepodids
per fish of initial infection confirmed the lack of Atlantic
salmon’s ability to clear the parasite. However, the micro-
array analyses suggested rapid and sizeable transcrip-
tomic responses to lice. The total number of differentially
expressed features was 2438 in skin and 922 in spleen
(Figure 1A and Additional file 1). Given low redundancy
of the platform, these numbers are close to numbers of
differentially expressed genes (DEG). While the magni-
tude of responses remained relatively stable within the
whole study period in the spleen, the number of genes
with expression changes in skin decreased markedly after
5 dpi. For validation of microarray results, genes that
covered the whole range of expression ratios were cho-
sen, and RT-qPCR analyses were performed in the same
individuals (Figure 1B). The results of two independent
methods were in good concordance: coefficients of linear
regression and correlation (Pearson r) were equal to 0.84
and 0.80 respectively (complete RT-qPCR results are in
Additional file 2).
Hierarchical clustering suggested high consistency of
t h eg e n ee x p r e s s i o nc h a n g e s( F i g u r e1 C ,D ) .T h es a m -
ples (biological replicates)w e r eg r o u p e db yt h et i m e -
points with exclusion of one outlier (D15-1), which
deviated from the common trend in both analyzed tis-
sues. The samples from spleen and skin were divided in
two large clusters (days 1-5 and days 10-15), which were
sharply separated, especially in the skin. This suggested
a bi-phasic response to lice and the K-mean clustering
confirmed abrupt expression changes in a major part of
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Page 2 of 17genes between days 5 and 10 (data not shown). A nota-
ble example of bi-phasic regulation is a group of splenic
proteases (trypsins and chemotrypsins, carbopeptidases
and carboxylic ester hydrolases, elastase, proteinase E
and choriolytic enzyme) and proteins involved in regula-
tion of exocytosis (syncollin and endoplasmic reticulum
protein ERp27). The microarray results were confirmed
with RT-qPCR (Figure 2 and Additional file 3).
Search for the enriched functional classes and path-
ways in the present microarray data illustrate the the-
matic associations of gene expression changes. By
functions of DEG, responses to lice were much more
diverse and complex in skin, which was the target site
for the parasite (Table 1). The changes were associated
with cell maintenance (metabolism of amino acids and
sugars, mitochondrion and cytoskeleton (including
motor proteins), protein biosynthesis, modification and
transport, regulation of redox status, DNA replication
and repair), cell communication and reparation of
tissues. By result of statistical analysis, enrichment was
greatest in classes related to basic metabolic functions
(mitochondrion, glycolysis and ribosomes). The immune
functional groups comprised a relatively small fraction
of changes in the skin (only two KEGG pathways) but
were predominant in the spleen (five of ten terms
included in Table 1); inflammatory response and com-
plement and coagulation cascades were the most
enriched terms. The study focused on the immune
responses and therefore in presentation of results prefer-
ence is given to genes with known immune roles.
Humoral immunity and inflammation
Rapid responses to the parasite and transmission of signal
from the damaged sites to the internal organs were con-
firmed with up-regulation of pro-inflammatory genes in
both skin and spleen. The complement system is part of
both innate and adaptive immune system, and plays a
major role in recognition and elimination of pathogens.
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Figure 1 An overview of transcriptomic responses to lice. A: The number of differentially expressed features in skin and spleen (mean log2-
Expression Ratio (ER) > |0.8|, p < 0.01, one sample t-test. B: Comparison of microarray and RT-qPCR results, pooled data for 18 genes analyzed in
skin and spleen, n = 225. C, D: Hierarchical clustering of skin and spleen samples by expression profiles of DEG (Pearson r, Ward’s method).
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Page 3 of 17Several lectins with early (1 dpi) induction in skin
( F i g u r e3 )h a v eu n k n o w nr o l e sb u tm a yb en e e d e df o r
detection of pathogen; the calcium dependent (C-type)
lectin domain family 4 E is expressed in macrophages and
other Ag presenting cells [15]. In theory, lectins can acti-
vate one of the complement pathways. In this respect, it is
noteworthy to mention down-regulation of several genes
for C1Q-like proteins that can trigger the classical path-
way, which could mean preferential activation of the lectin
pathway. Decreased expression was shown for two nega-
tive regulators of complement: CD59 and C4b-binding
protein. Phospholipase A2 and prostaglandin E synthase 3
are involved in biosynthesis of inflammatory regulators
and several more immune effectors showed rapid up-regu-
lation. The RT-qPCR analyses of IL-1B, IL-12, TNF-a did
not find significant expression changes in skin, spleen, and
head kidney (see Additional file 2). The components of the
NFKB pathway changed expression in both directions
while a panel of IFN-dependent proteins were down-regu-
lated; many of these have shown strong responses to
viruses [14]. Given large distance between the spleen and
the skin, we could anticipate preferential regulation of
genes for proteins exported to plasma and body fluids
including acute phase proteins (serum amyloids, lysozyme
C and transferrin) (Figure 4). Several lesser known pro-
teins have been attributed to this functional group; these
are jeltraxin, which is similar to C-reactive P component
and serum amyloid P component, differentially regulated
trout protein 1 [16] and LPS neutralizing protein cathelici-
din. In addition, rapid up-regulation was observed in a
number of possible pro-inflammatory genes including sev-
eral TNF-dependent genes (TNF decoy receptor,
metalloreductase STEAP4 and TSG6). In parallel, a large
group of genes for plasma proteins decreased expression:
highly coordinated changes were seen in the components
of complement and coagulation cascade (26 genes) and in
a diverse group of 55 genes that among other included
apolipoproteins and glycoproteins, macroglobulins and
protease inhibitors, proteins binding copper, iron and
heme, scavengers, chemokines and cytokines (Figure 5A).
The temporal patterns of inflammatory changes were
different in the analyzed tissues. In skin, many genes had
similar expression profiles during 1-5 dpi, while in spleen
the acute phase proteins showed a short-term increase
only at 1 dpi. However in both skin and spleen the char-
acter of innate immune responses changed dramatically
after 5 dpi. The switch of transcriptomic program was
marked with abrupt temporary down-regulation of sple-
nic plasma proteins, which was similar to that observed
at 1 dpi but with greater magnitude (Figure 5A). A hall-
mark of the second phase was up-regulation of several
matrix metalloproteinases: MMP9 (gelatinase) and
MMP13 (collagenase 3), which was observed in skin,
spleen and head kidney - the latter was analyzed with
RT-qPCR (Figure 5B-D). These inducible enzymes have a
wide range of roles, from massive degradation of extra-
cellular matrix and tissue remodeling to limited proteoly-
sis and subtle regulation of immune processes [17,18].
Various pro-inflammatory genes including chemokines
and effectors showed up-regulation after 5 dpi.
Cellular responses, acquired immunity
The gene expression profiles in skin (Figure 6A) indi-
cated rapid alterations of the composition of immune
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Figure 2 Expression changes of proteases in spleen. A: Microarray data are mean log2-ER ± SE for 24 genes with highly coordinated
expression profiles. The lists of genes and accession numbers are in Additional file 3. B: RT-qPCR analyses performed with SYBR Green assays.
Data are mean -ΔΔCt ± SE. Significant differences from control (n = 4, P < 0.01) are indicated with**. Note significant differences from control of
all genes at all time points. CheTry, Chemytrypsin; CarPep, Carboxypeptidase; Ela, Elastase; Try2, trypsin-2; Try3, trypsin-3.
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Page 4 of 17cells in the target site. Stable up-regulation during 1-5
dpi was observed in a panel of signal transducers: LCK2,
protein kinase D3, RAS homologue member G (RhoG),
spleen tyrosine kinase (SYK), GRB2-related adaptor pro-
tein 2, G protein-coupled receptor kinase 5, RAS gua-
nyl-releasing protein 2, which are known for their
important roles in regulating immune cell movement
[19,20]. Several of these genes have shown preferential
expression in salmon peripheral blood leukocytes in pre-
vious microarray study [14]; however, their association
with specific cell lineages remains unknown. Microarray
analyses showed decreased abundance of transcripts for
proteins that have a major part in transendothelial
migration of leukocytes, including annexin 2, myosin
9 - a non-muscle motor protein, and integrin beta; CD9
and CD63 expressed on leukocyte membranes interact
with integrins and proteins of extracellular matrix.
Down-regulated CD53 mediates activation of leukocytes
and MafB is the myeloid associated differentiation mar-
ker. We did not see induction of myeloid-specific genes
while a number of events suggested recruitment and
activation of lymphoid cells. Increase was observed in a
panel of T-cell-specific genes including T-cell receptor
alpha (TCRa), serine/threonine-protein phosphatase 2B,
L-plastin, drebrin suggesting preponderance of T
lymphocytes among immune cells that appeared in the
target sites (Figure 6A). Up-regulation of TCRa and
CD3ε in the head kidney at 1 dpi and decrease at 5 dpi
Table 1 Enrichment of GO classes and KEGG pathways in the lists of DEG
Functional group, pathway Features
1 p-value
2 Vocabulary
Skin
Mitochondrion 177 / 1104 0.000 GO
Glycolysis / Gluconeogenesis 33 / 117 0.000 KEGG
Pentose phosphate pathway 13 / 48 0.009 KEGG
Glutamate metabolism 16 / 48 0.000 KEGG
Glutathione metabolism 13 / 49 0.011 KEGG
Ribosome 47 / 172 0.000 GO
Protein folding 33 / 178 0.015 GO
Protein modification 44 / 246 0.009 GO
Protein transport 78 / 473 0.004 GO
Cytoskeleton 89 / 579 0.013 GO
Myosin complex 23 / 86 0.000 GO
Endoplasmic reticulum 140 / 992 0.027 GO
Cell redox homeostasis 11 / 43 0.027 GO
Double-strand break repair 7 / 24 0.050 GO
Anti-apoptosis 41 / 200 0.001 GO
Positive regulation of apoptosis 12 / 51 0.037 GO
Antigen processing and presentation
3 17 / 69 0.007 KEGG
Leukocyte transendothelial migration 32 / 186 0.043 KEGG
Cell adhesion 83 / 545 0.020 GO
Tight junction 38 / 208 0.011 KEGG
Heparin binding 18 / 90 0.043 GO
Keratinization 8 / 21 0.006 GO
TGF-beta signaling pathway 24 / 113 0.008 KEGG
Spleen
Inflammatory response 22 / 213 0.000 GO
Complement and coagulation cascades 29 / 85 0.000 KEGG
Peptidase activity 23 / 145 0.000 GO
Acute-phase response 8 / 20 0.000 GO
Chemotaxis 10 / 81 0.003 GO
Basement membrane 10 / 68 0.000 GO
Cell adhesion 36 / 545 0.020 GO
Extracellular space 47 / 375 0.000 GO
Heparin binding 13 / 90 0.000 GO
Neuroactive ligand-receptor interaction 14 / 173 0.036 KEGG
1 Numbers of genes among DEG and on the microarray platform.
2Yates’ corrected chi-square.
3Immune related groups and pathways are highlighted with bold.
Tadiso et al. BMC Genomics 2011, 12:141
http://www.biomedcentral.com/1471-2164/12/141
Page 5 of 17(Figure 6D) implied rapid recruitment of T-cells from
this depot. The nature of these cells remains unknown.
No expression changes of CD8 were detected though
the microarray platform included probes to alpha and
beta chains whose performance was confirmed in stu-
dies with viral diseases including cardiomyopathy syn-
drome (CMS), heart and skeletal muscle inflammation
(HSMI), and the infectious salmon anemia (ISA)
(unpublished results). The RT-qPCR analyses found a
short-term up-regulation of CD4-1 in skin (Figure 6C).
An interesting finding was expression changes of genes
that control differentiation of lymphocytes. This was
shown by an increase in several genes that regulate early
lymphopoiesis, such as kin of IRRE like 3, myeloid/
Gene D1 D3 D5 D10 D15
Interferon regulatory factor 1  -0.23 -1.16 -0.98 0.51 -0.08
Gamma-interferon-inducible thiol reductase   -0.58 -1.28 -1.06 0.30 0.29
Interferon regulatory factor 2-binding protein 1  -0.79 -1.43 -0.75 0.40 -0.21
Interferon-gamma receptor alpha chain -0.75 -1.29 -1.14 0.31 0.05
Interferon-inducible protein Gig2-like  -0.92 -1.30 -1.13 0.01 0.06
Probable ATP-dependent RNA helicase DHX58  -1.36 -1.56 -1.38 -0.36 -0.08
Janus kinase 1  -1.62 -1.03 -0.64 -0.56 -0.03
VHSV-induced protein-10 -0.91 -1.51 -0.77 -0.61 -0.15
Sacsin  -1.37 -1.48 -1.38 -0.86 0.16
Interferon-induced protein 44  -1.05 -1.62 -0.74 -0.79 -0.55
Interferon-induced with tetratricopeptide repeats 5  -1.49 -1.06 -0.78 -1.16 0.04
Interferon regulatory factor 7  -1.19 -0.39 -1.39 -0.92 -0.50
Interferon-induced protein 44  -0.90 -1.35 -0.93 -1.07 -0.78
Inducible nitric oxide synthase -2.01 -1.32 -0.69 -0.06 0.02
C-reactive protein   -1.31 -1.81 -1.80 0.41 -0.33
Lysozyme g  -1.35 -1.14 -1.04 -0.39 -0.45
Cytochrome b558 alpha-subunit -2.70 -0.71 -1.33 -0.72 -0.29
Integrin beta-1   -0.08 -1.22 -1.55 1.38 0.49
Integrin beta-2  -1.00 -1.02 -1.01 1.28 0.33
Matrix metalloproteinase-9  -0.31 -0.95 -0.72 2.19 0.47
Collagenase 3   -0.44 -0.30 -0.11 2.52 -0.14
Matrix metalloproteinase-9  -1.51 -0.78 -1.52 1.67 0.74
Serum amyloid A-5 protein  -0.95 -3.33 -3.59 2.88 1.68
Cathelicidin antimicrobial peptide  -1.62 -2.16 -3.25 1.84 0.26
C3a anaphylatoxin chemotactic receptor -0.58 -0.05 -0.04 1.42 0.57
Down >32 32-5.7 5.6-2.6 2,5-1.7 1.6-1.3 1.3-1.6 1.7-2,5 2.6-5.6 5.7-32 >32 Up
Gene D1 D3 D5 D10 D15
Rhamnose-binding lectin WCL1  2.07 0.42 0.82 0.09 0.61
CD209 antigen-like protein D  1.07 0.94 0.63 -0.30 -0.19
C-type lectin domain family 4 E  1.60 4.28 1.60 -0.03 0.53
Mannose receptor C type 1   1.45 0.46 0.57 -0.39 0.32
Mannose receptor, C type 2  3.15 4.10 2.09 0.50 0.37
Mannose-binding protein C   -0.58 -3.09 -3.34 0.25 0.29
Polymeric immunoglobulin receptor  1.72 1.18 1.33 -0.47 0.53
Complement factor H1 protein  2.79 2.61 2.44 0.15 1.16
C4b-binding protein alpha chain   -0.78 -1.50 -1.06 0.40 -0.50
CD59 glycoprotein   -0.94 -1.67 -1.14 -0.43 -0.52
Complement C1q-like protein 4  -0.44 -1.79 -1.84 -0.18 0.06
Complement C1q subcomponent subunit B  -1.08 -1.92 -1.61 0.66 -0.24
C1q-like protein 4 -2.84 -0.24 0.56 5.24 3.78
Prostaglandin E synthase 3 1.42 0.62 0.49 0.01 0.29
Phospholipase A2, group VI isoform b  1.41 1.03 1.18 -0.29 0.09
C-C chemokine receptor type 3  1.77 0.93 0.90 -0.22 0.13
Amyloid beta A4 protein , isoform a  2.63 1.74 2.38 -0.01 1.14
SAPS domain family member 3  2.37 3.37 1.07 -0.21 0.14
Tax1   2.01 1.90 1.19 0.15 0.11
Nuclear factor NF-kappa-B p100 subunit  1.38 0.70 0.86 -0.08 0.09
Tax1   -1.91 -1.49 -1.58 0.04 -0.29
Transcription factor AP-1  -1.04 -0.87 -0.25 -0.63 -0.33
Nuclear factor NF-kappa-B p100 subunit  -0.69 -1.08 -0.80 -0.10 -0.23
Transcription factor jun-B  -0.01 -1.44 -1.23 0.61 0.18
Galectin-9  -0.42 -1.14 -1.26 0.64 0.42
Figure 3 Examples of immune genes with differential expression in skin (microarray results). Data are mean log2-ER (n = 4).
Gene D1 D3 D5 D10 D15
Acute phase serum amyloid A (SAA) 3.17 -0.35 0.53 -0.69 0.72
Cathelicidin antimicrobial peptide 1.88 -0.13 0.70 -0.54 0.83
Differentially regulated trout protein 1 2.54 0.89 0.40 -2.17 -0.70
Jeltraxin precursor 1.51 -0.06 0.90 -0.39 0.03
Lysozyme C II precursor 1.40 -0.11 0.20 -0.76 0.75
Metalloreductase STEAP4-1 1.59 0.92 -0.18 -0.11 0.20
Metalloreductase STEAP4-2 2.05 1.47 0.08 0.45
Serum amyloid A 2.42 -0.91 0.49 -1.70 0.25
Transferrin 1.81 0.54 -2.47 -0.82 0.58
C-X-C motif chemokine 10 precursor 1.04 -0.09 0.94 -1.39 0.24
C type lectin receptor A 1.29 0.91 0.23 -0.67 0.51
TNF decoy receptor 1.16 -0.42 0.14 -1.44 0.93
Tumor necrosis factor-inducible protein  1.55 0.52 0.63 -1.02 0.88
MAP kinase-activated protein kinase 3 0.61 0.52 0.98 2.16 -0.05
Natterin-like protein -0.09 1.13 -0.14 1.63 0.02
Gene D1 D3 D5 D10 D15
C-C motif chemokine 28-1 -0.04 0.11 0.80 1.85 -0.96
C-C motif chemokine 28-2 0.14 -0.07 0.77 1.84 -0.21
C-x-c chemokine receptor type 3A-1 0.17 0.59 0.45 1.23 0.51
Complement factor H1 protein 0.46 0.39 0.75 2.31 -0.11
Complement factor D precursor 0.35 0.30 0.17 1.56 0.96
IL-8 receptor -0.44 1.24 0.66 1.87 1.27
Interleukin-2 receptor subunit beta 0.01 -0.04 0.85 1.90 -0.34
Neutrophil cytosolic factor 1 0.41 1.09 0.09 1.01 1.09
Myeloperoxidase precursor -0.23 -0.31 0.05 1.27 0.93
Arachidonate 5-lipoxygenase-activating p -0.11 0.63 0.13 1.16 0.15
Leukotriene A-4 hydrolase -0.11 0.77 -0.05 1.02 0.79
Rhamnose-binding lectin WCL1  0.44 0.22 0.91 2.14 -0.25
Matrix metalloproteinase 0.27 1.62 0.70 1.59 1.31
Matrix metalloproteinase-9 -0.30 1.63 0.00 1.71 1.44
Collagenase 3 precursor -0.27 1.64 0.21 1.70 1.72
Down >32 32-5.7 5.6-2.6 2,5-1.7 1.6-1.3 1.3-1.6 1.7-2,5 2.6-5.6 5.7-32 >32 Up
Figure 4 Examples of immune genes with differential expression in spleen (microarray results). Data are mean log2-ER (n = 4).
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Page 6 of 17lymphoid or mixed-lineage leukemia, notch 1, Ikaros,
growth factor independent (Figure 6A). Translin and
translin-associated X interacting protein 1 are required
for somatic recombination of genes encoding immuno-
globulins (Ig) and T-cell receptors [21], while BTG3 and
IRF4 stimulate their transcription. This may mean that
terminal differentiation of T-cells takes place in the
infected sites and we came to a similar conclusion in
our studies of a viral disease CMS (unpublished data).
We did not find any indications of T-cell mediated
immunity in subsequent responses. Down-regulation of
MHCI, B2M in skin and head kidney during 1-5, and
15 dpi, and MHCII in skin 15 dpi (Figure 6), suggested
absence of antigen presentation to T-cells. After 5 dpi
the T-cell related genes showed no expression changes
in skin. In contrast, there was evidence for the
development of B cell mediated immunity. Despite an
early regulation in skin of polymeric immunoglobulin
receptor (pIgR), a key molecule in transcytosis of Igs
(Figure 3), neither microarray nor RT-qPCR analyses
showed early regulation of Ig genes in skin. Rapid
(1 dpi) up-regulation of IgM and IgT in the head kid-
ney followed with decrease at 5 dpi (additional file 2)
suggested recruitment of B cells. However since no
increase of B cell-specific transcripts were detected in
skin at 1-3 dpi, they probably did not appear in the
target site. However, RT-qPCR analyses revealed gra-
dual increase of IgM and IgT transcripts from 10 to
15 dpi (Figure 7). Up-regulation of several isoforms of
lymphocyte G0/G1 switch protein 2 at 5 dpi (data not
shown) probably marked an onset of adaptive immune
responses in the spleen. A large panel of Ig transcripts
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Gene D1 D3 D5 D10 D15
Tyrosine-protein kinase SYK  3.51 2.11 2.82 -0.48 1.16
Rho-related GTP-binding protein RhoG   1.78 1.19 1.66 0.10 0.91
Nuclear receptor coactivator 7, isoform 1 1.68 2.40 1.89 -0.12 0.55
LCK2 1.21 1.32 0.68 -0.16 0.13
protein kinase D3  1.15 0.83 1.23 -0.32 0.25
GRB2-related adaptor protein 2  0.75 2.02 1.03 0.28 0.37
G protein-coupled receptor kinase 5  0.69 1.71 0.89 -0.09 0.28
myeloid/lymphoid or mixed-lineage leukemia   1.89 1.71 1.25 -0.55 0.55
kin of IRRE like 3  1.63 0.77 1.49 -0.18 0.55
DNA-binding protein Ikaros  1.14 1.40 1.01 -0.90 0.22
notch 1 0.79 1.50 0.80 -0.53 -0.30
Myeloid-associated differentiation marker  -0.57 -1.27 -1.40 0.61 0.00
Hematopoietic lineage cell-specific protein  -0.89 -0.76 -1.28 0.61 0.12
Transcription factor SOX-4  -0.99 -1.84 -0.43 -0.56 -0.36
Transcription factor MafB  -1.28 -0.94 -0.73 0.52 -0.16
Interferon regulatory factor (IRF4)  3.06 4.66 1.85 -0.03 0.33
Translin  2.99 4.23 1.70 -0.57 0.25
Tanslin-associated factor X interacting protein 1  2.81 4.53 1.85 0.24 0.85
Serine/threonine-protein phosphatase 2B   3.62 3.00 3.35 0.62 1.73
Drebrin-like protein  3.25 3.94 1.54 -0.16 0.37
modified T cell receptor alpha  3.14 4.05 1.57 -0.19 0.19
T cell receptor alpha-1  2.92 3.95 1.40 -0.06 0.04
Growth factor independent 1  2.68 3.38 1.07 -0.41 0.30
Down >32 32-5.7 5.6-2.6 2,5-1.7 1.6-1.3 1.3-1.6 1.7-2,5 2.6-5.6 5.7-32 >32 Up
Gene D1 D3 D5 D10 D15
RAS guanyl-releasing protein 2  2.64 3.49 1.15 -0.33 -0.03
SRC-like-adapter  2.42 0.64 1.80 -0.25 0.73
kinase C-binding protein 1  1.87 1.62 1.37 0.00 0.46
lymphocyte cytosolic protein 1  1.68 4.19 1.76 0.10 0.54
T cell receptor alpha-2  1.68 4.89 2.32 0.34 0.51
T cell receptor alpha-3  1.56 4.54 1.83 0.14 0.47
T cell receptor alpha-4  1.08 4.52 2.19 0.06 0.33
BTG3 associated nuclear protein isoform a  1.25 1.29 1.40 -0.29 0.20
CD4 T-cell surface glycoprotein -0.93 -1.07 -0.31 -0.66 0.14
CD3gammadelta-A  -1.18 -0.88 -0.24 -0.56 -0.32
Plastin-2 lymphocyte cytosolic protein -1.38 -1.13 -1.20 0.56 0.08
CD63 antigen  -0.98 -1.69 -0.79 0.74 0.28
CD9 antigen  -1.03 -1.47 -0.68 -0.31 -0.48
Integrin beta-1   -1.23 -1.71 -1.81 0.03 0.36
Integrin beta-1   -0.08 -1.22 -1.55 1.22 0.65
Integrin beta-2  -1.00 -1.02 -1.01 1.14 0.47
Leukocyte surface antigen CD53  -1.25 -1.29 -0.49 -0.45 -0.16
Annexin A2-A  -1.64 -1.83 -1.63 0.51 0.28
Myosin-9  -1.71 -1.15 -1.68 0.43 0.34
nonclassical MHC class I antigen 1.13 0.86 0.67 -0.63 -0.17
Beta-2-microglobulin-1 -0.77 -1.77 -1.13 -1.34 -0.56
Beta-2-microglobulin-2 -1.39 -1.79 -1.39 -0.09 -0.64
H-2 class I histocompatibility antigen  -1.64 -2.41 -1.66 -0.50 -0.40
Figure 6 Examples of genes involved in cellular immunity with differential expression in skin and head kidney. A: microarrays in skin,
data are mean log2-ER (n = 4). The gene functions are explained in the text. B-D: RT-qPCR analyses of MHC and T-cell markers in skin (B &C),
and in head kidney (D) performed with SYBR Green and TaqMan based assays. Data are mean -ΔΔCt ± SE. Significant differences from control
(n = 4, P < 0.05) are indicated with *.
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Page 8 of 17showed decrease at 10 dpi followed with up regulation
at 15 dpi.
Discussion
The Atlantic salmon is highly susceptible to L. salmonis
and the present study was thus designed to identify host
responses due to the early infectious stages from 1 to 15
dpi. After settlement, copepodids spend 7 to 11 days (at
9°C) on the host before all have completed the molt and
are physically attached to the host by a frontal filament.
We focused on the first 15 days after infection and the
host responses were related to copepodids (day 1 to 5),
mixed copepodid and chalimus (day 10) and chalimus
( d a y1 5 )( F i g u r e8 ) .W eu s e da d v a n t a g e so fm u l t i p l e
-2.0
-1.0
0.0
1.0
2.0
3.0
Ig
T-cells
MHC I
MMPs
-5.6
-4.2
-2.8
-1.4
0.0
1.4
2.8
Ig
Acute phase
MMPs
Proteases
LiceS LiceR
4
0
2
0
6
0
Lice
Count (%)
C
A B D
DPI 30 35 25 10 15 3 15
Phase II Phase I
Copepod Chalimus Pre-adult Adult
-
Δ
Δ
C
t
 
/
 
L
o
g
2
-
E
R
Skin
Spleen
Lice secretions
Secondary infections
Cortisol, stress
High host mortality
Figure 8 Summary of salmon responses to lice in skin and spleen. The present study dealt with responses until 15 dpi as shown in the left
side of the figure. Host responses to mature lice stages from literature are shown by a dotted line (right side). The figure illustrates the bi-phasic
responses to L. salmonis with abrupt changes in gene expression profiles taking place between 5 and 10 dpi, when lice molts from copepodids
to chalimus. Ig genes show an initial decrease followed by gradual increase. MHC and related genes are down regulated. A: early sensing was
witnessed both in skin and spleen. At point B, PGE2 and other secreted components start to increase [31,34] and this may lead to immune
modulation, and can partly explain the pronounced shift in immune responses. Resistant salmonids (e.g. coho salmon) reject lice at point C, 7-14
dpi [10,11] and the number of lice per fish (LiceR) starts to decrease (see the hypothetical curve on the right side). In susceptible species
including Atlantic salmon, the lice number (LiceS) remains relatively stable until they reach the pre-adult/adult stages where lice falls off the fish
possibly due to aging, competition, and other factors. In spleen, secretory proteases show dramatic fluctuation. Increased MMPs in all tissues
suggest inflammation. When the louse enters the pre-adult stage (i. e, ~ after day 20), the effects on host increase and can cause high mortality.
The risk of secondary infections increase, and cortisol levels rise significantly (point D), which indicates severe stress [9,26,34]. At this point, it is
difficult to differentiate the direct and stress mediated effects of lice [26]. The figure summarizes responses observed after single pulse infection.
However, under natural conditions, salmon can carry parasites at different developmental stages and responses can be modified with diverse
environmental factors.
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Page 9 of 17gene expression profiling with a 21 k oligonucleotide
microarray, which covers the major fraction of protein-
coding genes in Atlantic salmon. Transcriptional
responses to salmon louse were analyzed in skin, the
first entry point for the parasite, and in the spleen. The
latter was selected due to the important role as a lym-
phoid organ [22] and furthermore, in our previous
microarray study [13] we found greater gene expression
changes in salmon spleen in comparison with the head
kidney, another major immune organ of teleost fish.
Our data revealed a strong host response one day post
infection with a pronounced switch in gene expression
pattern taking place between 5 and 10 dpi. This switch
corresponds to the period where lice molt from copepo-
dids to chalimus I ending up with a new transcription
pattern at day 15 where all surviving parasites have
developed into chalimus (Figure 8). In contrast to Pacific
salmon, Atlantic salmon show limited tissue response to
L. salmonis infections [10]. The reason for this is
unknown but a recent study [23] indicates that the Paci-
fic and Atlantic form of L. salmonis may represent two
different species and this may account for some of the
differences. In addition to immune parameters, differing
resistance of salmonids to L. salmonis can be related to
the structure of skin, composition of mucus, and envir-
onmental factors [5,9-12,24].
Little is known about how teleosts respond to para-
sites in general and to the salmon louse in particular. By
using a microarray approach it is possible to screen a
large number of markers and to identify both known
and novel host responses to the pathogen of interest.
Use of genomic tools allowed reconsidering of views
based on the studies with limited sets of immune para-
meters. It was thought that louse do not cause signifi-
cant effect in Atlantic salmon at early stages [25]. Weak
inflammation at the site of attachment was regarded as
a plausible explanation of higher susceptibility of Atlan-
tic salmon in comparison with closely related species,
such as sockeye and coho salmon (reviewed in [26]).
However, transcriptomic analyses did not show low
levels of immune responses to lice in Atlantic salmon.
Dramatic gene expression changes were seen immedi-
ately after infection in the target site (skin) and in the
spleen; both local and systemic sensing was rapid and
large by scale. Given that most differentially expressed
genes are not those that are commonly included in stu-
dies of salmon immunity, it would be difficult to detect
these changes based on the candidate genes approach.
An unexpected finding was involvement of splenic pro-
teases. Dramatic expression changes of a group of genes
encoding functionally related proteins imply their
important role, which remains completely unknown.
Thus, results of transcriptome analyses suggest that low
resistance of Atlantic salmon to lice appears to be
accounted for by the character of immune response
rather than the scale of the response. The results eluci-
dated immune processes that are activated but most
likely do not confer substantial protection against the
parasite.
High-throughput analyses revealed a bi-phasic
response to lice. Modulation of responses by the parasite
can be considered as one possible explanation. It is well
documented that parasites have the ability to modulate
host response to avoid rejection by the host and by this
increase survival. For ectoparasites this can be con-
ducted by releasing excreted products to the host sur-
face or the site of feeding. Based on knowledge from
other ectoparasites it is likely that L. salmonis releases a
diversity of secretory/excretory products when it settles
o nas u i t a b l eh o s t .R e c e n t l yi tw a ss h o w nt h a th o r s ef l y
(Tanabus yao) release a wide diversity of molecules
when feeding and these molecules where shown to
affect a range of biochemical and physiological processes
in the host [27]. Salivary gland extracts from ticks sup-
press lymphocyte proliferation and cytokine response
[28]. Parasites such as Leishmania utilize a number of
immune avoidance strategies [29], some of which resem-
bling that of tumor cells [30]. Immune suppression by
lice has been reported in several publications. Salmon
louse releases molecules that affect host response [31]
and a few of these have been identified [31,32]. Lice
produce PGE2, trypsin-like proteases, and other pro-
ducts that suppress the immune system of Atlantic sal-
mon [33]. Significant reduction of oxidative and
phagocytic activities of macrophages [25], and reduced
transcription of IL-1b and COX-2 in lice infected sal-
mon has been reported [31,34]. In the present study, a
panel of pro-inflammatory cytokines analyzed with RT-
qPCR (IL1-b,I L 1 R 1 ,T N F a and IL-12) did not show
significant response to lice. Furthermore, our findings
indicated down-regulation of Ag presentation after
infection with salmon lice, possibly affecting the conven-
tional T-cell mediated adaptive immune response. Simi-
lar down-regulation of genes involved in Ag processing
has been documented in Atlantic salmon infected by the
protozoan ectoparasite that causes amoebic gill disease
(AGD) [35]. This is interesting because L. salmonis is
also implicated as a possible risk factor for AGD [36]. In
similar host-parasite interaction studies, MHC II gene
expression decreased in head kidney and skin after
infection of carp with Trypanoplasma borreli [37], and
rainbow trout with Gyrodactylus derjavini [38]. Besides,
our microarray data shows down-regulation of lysosomal
proteases (cathepsins), which process exogenous anti-
gens for presentation by MHC II [39,40].
The character of inflammation changed during the
copepodid-chalimus transition as well. Commonly acute
and chronic inflammation is associated with cells of
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Page 10 of 17myeloid origin and lymphocytes, respectively. However,
an opposite trend was observed in our study. As shown
in Figure 6A and 6C, gene expression changes provided
evidence for a rapid recruitment of T-cells in the
damaged sites, indicating a short term T-cell mediated
response early during infection (1-5 dpi), which comple-
tely disappeared after 5 dpi. It is worth noting that
Atlantic salmon possesses diversified numbers T-cells
and receptors [41,42]. Their functional roles remain
undetermined, as the true cytokine profile of CD4
response is dependent on interactions between the
pathogen and antigen-presenting-cells [43]. In mammals,
natural T- cells expressing a conserved TCRa-chain can
exhibit both CD4
+ and CD4
-/8
- double-negative pheno-
type [44]. It is possible that in the present study, at least
some of the lymphocyte responses could be MHC-inde-
pendent, possibly belonging to unidentified lineages that
are not associated with acquired immunity or immune
memory either, as Atlantic salmon used in this study
was not immunized previously against lice. These cells
could be similar to innate T-like cells which function as
natural killer T-cells recognising antigens presented by
non-classical MHC molecules [45]. Microarray data
showed up-regulation of non-classical MHCI molecules
in the skin (Figure 6A). Induction of genes that control
early stages of lymphocyte differentiation suggests invol-
vement of precursor cells, which either resided in skin
or were delivered with blood. Concurrent down-regula-
tion of several genes in skin that control transendothe-
lial migration indicates the depletion of leukocytes.
A hallmark of transit from acute to chronic inflamma-
tion was the systemic increase of MMP9 (gelatinase)
and MMP13 (collagenase), which did not show expres-
sion changes during the first phase. Earlier we found
preferential expression of these genes in salmon leuko-
cytes [14]. The changes of transcript abundance could
be due to either MMPs induction in activated resident
immune cells (macrophages) or influx of leukocytes.
The latter possibility is supported with simultaneous up-
regulation of integrins and C3a anaphylatoxin chemotac-
tic receptor in skin and neutrophil cytosolic factor in
spleen (Figs 3 & 4). The observed changes can be a con-
sequence of chronic stress and increased production of
cortisol. In this respect, it is noteworthy that Fast et al.
[34] found no changes of plasma cortisol levels during
the first 15 dpi in Atlantic salmon infected with L. sal-
monis, while its increase at 26-33 dpi was in parallel
with the induction of pro-inflammatory mediators
(IL-1b and TNFa). Overall, cortisol has an immune sup-
pressive action. However, a remarkable feature of sal-
mon MMPs is induction with both inflammatory stimuli
[46] and stress [47]. Recently we observed up-regulation
of MMPs in salmon with cortisol implants (manuscript
under preparation). Previously we reported a sustained
induction of MMPs as a characteristic feature of lice
infection in Atlantic salmon [13]. MMP-9 in carp LPS
stimulated leucocytes shows a bi-phasic profile: increase
until 48 hours, decline, and another increase at
168 hours, indicating its role both in early inflammation
and later stages of tissue remodelling [17].
Vaccines are discussed as a possible measure against
salmon louse. Immunization of fish against L. salmonis
may be facilitated by an improved understanding of the
adaptive immune system and molecules involved
therein, particularly how the host responds to parasites.
One of the limitations with vaccine development could
be the limited exposure of louse to blood and thereby
serum antibodies (reviewed in [8]), and mucosal immu-
nity might play a major role here as L. salmonis are
colonizers of cutaneous mucosa of salmonids. Mucosal
epithelial cells serve as an initial barrier and, in addition,
they are involved in adaptive immunity by Ag presenta-
tion and production of Igs along with complement, lec-
tins, CRP, lysozymes, proteolytic enzymes and other
effectors [48-50]. Antibodies at the surface of skin
mucus can block ectoparasites from infestation or
reduce infestation success [50]. IgT/IgZ is a teleost spe-
cific antibody class first discovered in rainbow trout and
zebrafish [51,52]. In salmon, there are three highly simi-
lar IgT sub-variants [53]. A recent study indicated that
they might be differentially regulated [54]. IgT is asso-
ciated with mucosal immunity, similarly to the mamma-
lian IgA [55]. IgT transcription in rainbow trout gut was
up-regulated more than 700 fold in fish that survived
infection with the parasite Ceratomyxa shasta [55]. This
immunoglobulin may coat gut luminal bacteria thus pre-
venting their attachment and invasion of the gut epithe-
lium [55]. While transcript levels of IgT and IgM in
mucosal tissues of naïve Atlantic salmon are relatively
low [53], we documented up to ten fold increase in skin
after infection with L. salmonis (Figure 7C). An increase
of IgT and IgM transcripts in skin and spleen may indi-
cate an onset of adaptive immune responses at later
stages of infection. It is worth mentioning here that
microarray data has showed an early up-regulation of
pIgR, a key molecule involved in the transport of Igs to
mucosal surfaces [55-57]. However, we did not observe
an early increase in Ig transcripts at the target site. In
addition to transcytosis of Igs, pIgR has an important
role in innate immune functions by attaching to host
and pathogenic factors, as well as protecting Igs from
proteolytic degradation [57,58].
Conclusions
In this paper we studied gene expression changes in
Atlantic salmon skin, spleen and head kidney during the
first 15 days post infection by L. salmonis,u s i n g
microarray and RT-qPCR (results are summarised in
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Page 11 of 17Figure 8). The findings clearly indicated early sensing at
1 dpi with induction of genes involved in innate
immune reactions, including lectins and enzymes of
eicosanoid metabolism in skin and acute phase proteins
in spleen. This was followed by regulation of a diverse
array of genes including MMPs and immunoglobulins.
The responses are bi-phasic with large shift in transcript
profiles of many genes during the time window corre-
sponding to the copepod-chalimus transition. Gradual
increase of Ig transcripts from 1-15 dpi in skin and
spleen, possibly indicated mounting of adaptive immu-
nity, which was supported by the up-regulation of puta-
tive lymphocyte G0/G1 switch proteins at 5 dpi in the
spleen. The responses, however, did not result in appre-
ciable level of protection, as revealed by the lice load on
fish at the end of the study. Down-regulation of the
antigen presenting MHCI and related molecules, and
absence of T-cell induction at later stages suggested lack
of T-cell dependent acquired immunity. Further bio-
chemical and functional studies of immune mechanisms
of IgT at mucosal sites in salmon, in the context of lice
infection will greatly contribute to a better understand-
ing of how adaptive immunity is orchestrated in salmon
with regard to mucosal defences. Furthermore, the large
group of secretory splenic proteases, which show the
greatest transcriptional fluctuations (up- and down-reg-
ulation), deserve a closer attention.
Methods
Challenge experiment
Atlantic salmon in the size range of 100-200 g, which has
not previously been in contact with L. salmonis,w e r e
placed in two different tanks containing full salinity
water (one for control and another for L. salmonis infec-
tion), at the Institute of Marine Research (IMR) in
Bergen. A hatchery and culturing system that enables
laboratory maintenance of salmon louse throughout its
life-cycle was developed recently [59]. Salmon louse of
L s G u l e ns t r a i n[ 5 9 ]w e r er e a r e di nt h eh a t c h e r ya n de g g
strings were collected and placed into an incubator until
they reached the copepodid stage. Atlantic salmon were
challenged with L. salmonis (approximately 100 copepo-
dids per fish). Commonly, approximately one third of the
copepodids added to a tank are found on fish during the
pre-adult/adult stages [59]. Following infection, tissues of
s k i n ,s p l e e n ,a n dh e a dk i d n e yw e r es a m p l e d1 ,3 ,5d p i
(corresponding to the copepod stage); 10 and 15 dpi
(chalimus stage). Control fish were sampled in a similar
manner (Figure 9). Immediately after sampling, tissues
were stored in liquid nitrogen and then transferred to
-80°C freezer. The fish were kept at a temperature of 9 ±
1°C during the entire experimental period, and fed with
commercial diet once daily. Louse load on each fish was
counted at the end of the experiment, 15 dpi.
RNA and cDNA preparation
RNA was isolated using the iPrep™ TRIzol
® Plus kit
(Invitrogen), and purified with RNeasy mini kit (QIA-
GEN). The quantity and quality of the total RNA was
assessed using a NanoDrop Spectrophotometer (Nano-
Drop Technologies) and an Agilent 2100 Bioanalyzer
(Agilent Technologies). Samples with RNA integrity
number (RIN) of 8 or higher were accepted for microar-
ray analyses. cDNA was synthesized by reverse tran-
scription of RNA using the qScript™ cDNA Synthesis
Kit (Quanta BioSciences). Total RNA and cDNA were
stored at -80 and -20°C respectively until use.
Microarray analyses
RNA amplification and labelling were performed using
Two-Colour Quick Amp Labelling Kit and Gene Expres-
sion Hybridization kit (for fragmentation of labeled
cRNA) following the manufacturer’si n s t r u c t i o n sf o r4×
44 k microarrays (Agilent Technologies). Nofima Mar-
in’s salmon oligonucleotide microarray SIQ3 (GEO
GPL10706) was fabricated by Agilent Technologies and
annotated with STARS bioinformatic package [14]. The
features were assigned to the functional classes (GO)
and pathways (KEGG). In addition, custom annotations
were implemented based on literature and other public
sources. Four biological replicates in each of 5 time-
points per tissue (skin and spleen), which comprise a
total of 40 microarrays (one array per sample), were
included in the analyses (Figure 9). The input of total
RNA used in each reaction was 500 ng. Pooled control
samples were prepared by mixing equal RNA concentra-
tions from each individual sample of control fish per
each time point. Individual samples of infected fish were
labeled with Cyanine 5 (Cy5), while control samples
were labeled with Cy3. Following labeling, amplification,
purification, and quantification, 825 ng of both the Cy5-
labeled test cRNA samples and Cy3-labelled control
samples were mixed and hybridized (competitively) to
the arrays (Figure 9). Over night hybridization (17-
hours, 65°C, and rotation speed of 10 rpm) was per-
formed in hybridization oven (Agilent Technologies).
After hybridization, arrays were washed with Gene
Expression Wash Buffers 1 and 2 and scanned with a
GenePix 4100A (Molecular Devices, Sunnyvale, CA,
USA). GenePix Pro 6.0 was used for spot to grid align-
ment, feature extraction and quantification. Assessment
of spot quality was done with aid of GenePix. After fil-
tration of flagged low quality spots, Lowess normaliza-
tion of log2-expression ratios (ER) was performed. The
differentially expressed genes (DEG) were selected by
criteria: log2ER > |0.8| and p < 0.01, (sample t-test, null
hypothesis log2ER = 0) in at least one time-point. The
microarray data were submitted to GEO, GSE26981
(skin) and GSE26984 (spleen).
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Eighteen differentially expressed genes from the micro-
array experiment, covering the entire dynamic range of
expression, were selected for verification with RT-qPCR.
Preference was given to immune genes and to genes
with unknown roles that showed strong responses to
the parasite. In addition, T-cell markers, immunoglobu-
lins (Ig), and genes of antigen presentation, and pro-
inflammatory cytokines were included. RT-qPCR
analyses were carried out with skin, spleen and head
kidney. TaqMan
® probe, and SYBR Green based Real-
Time PCR assays were designed using Primer express
3.0 (Applied Biosystems), and Beacon Designer 7.8
(PREMIER Biosoft, USA) respectively (Table 2). When
possible, primers or probes were designed to span
between two exons. Fast SYBR
® Green Master Mix
based PCR was performed using 7500 Fast Real-Time
PCR System (Applied Biosystems). The PCR reaction
mix contained 5 μlo fF a s tS Y B R
® Green Master Mix
(2 ×), 500 nM of each primer, and 2 μlo fc D N Ai na
final volume of 10 μl. Thermal cycling was carried out
according to the manufacturers protocol (Applied
Biosystems) as follows: enzyme activation at 95°C for
20 sec, followed by 40 cycles of denaturation (95°C for
3 sec), and annealing/extension (60°C for 30 sec). In
addition, Taqman probe based quantitative PCR was
performed on a few selected genes using the 7500 Fast
Real-Time PCR System (Applied Biosystems), and quan-
tification of mRNA was performed in a single step assay
(both RT and PCR steps carried out in the same tube)
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Figure 9 Set-up of the experiment. Atlantic salmon was challenged with L. salmonis at the copepod stage. Skin, spleen, and head kidney were
sampled from challenged and control fish at 1, 3, 5 dpi (corresponding to the copepod stage); 10 and 15 dpi (chalimus stage). Boxes a, b, and c
respectively indicate approximate positions on the fish where tissues (head kidney, skin, and spleen) were removed. A total of forty samples of
spleen and skin form infected salmon (4 individuals from the 5 time points) were used for microarray analyses. Test samples were labeled with
Cy5 and hybridized to pooled control samples labeled with Cy3 from the same time-points. Competitive hybridization to the arrays was followed
by washing, scanning, image analysis, and data analysis. Selected genes were analyzed with RT-qPCR.
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Page 13 of 17Table 2 Primer/ probe list
S.
N
Sequence Definition Code Primer/ probe (5’-3’) Product
length
GenBank Accession
(GI)
1. Apoptosis regulator Bcl-X Apo Fwd TACTAAGTGTTGCCGTTGA 109 209734267
Rev TAATCCAATCTGTGTCATTCTG
2. Beta-2-microglobulin precursor B2M Fwd CACAGACAGACACAGACA 102 221220497
Rev CAACGATTGACAGAATAGACTT
3. Carboxypeptidase A1 precursor CarPep Fwd AGCATACCAAGGACAACAC 75 209732661
Rev TACAACAGTACAATGACACAGT
4. Chymotrypsin B ChyTry Fwd CTGTCCATACTGTATATTGCTAT 111 209734305
Rev GCTATAATGCTTAGGTGTTGTA
5. Collagenase 3 precursor COL3 Fwd ATCTGTGCTTACTACTAATCAAC 81 209156091
Rev GGGCTTCATCTTCTTTACTG
6. Complement C1q subcomponent subunit B
precursor
C1qB Fwd CTGTCTGTCGTTGTCTTC 89 223649475
Rev ATGGTCTGTTGGTCTGTA
7. Elastase-1 Ela Fwd ACCGTCAACAAAGTCTTCA 75 S31963336
Rev CAGCAGAGCGATGTCATA
8. Fish virus induced TRIM protein TRIM Fwd GCATGGCACAATAATAACT 75 S35697379
Rev GTCCAGATACACTCCTAC
9. Trypsin-2 Try2 Fwd CAGTTGTCGGTTGAGATG 81 S18845530
Rev CAAGATGTGCCAGATAGC
10 Trypsin-3 Try3 Fwd CATTATTCTTCTCGCTCTG 81 S31964271
Rev TCATACCCTCCAACAATC
11 Tumor necrosis factor alpha TNFa Fwd ACAAAGAGGGCCAGGGATTC 100 126507266
Rev GAGGCCTGGCTGTAGACGAA
12 Interleukin-1 receptor-like protein IL1R1 Fwd AGCAGGATGTCCTCGGTCTA 202 185136290
Rev TGGGTAGCGGTGTAGTTTCC
13 Interleukin-1 beta IL1b Fwd ACCGAGTTCAAGGACAAGGA 196 186288127
Rev GCAGCTCCATAGCCTCACTC
14 Gamma-interferon-inducible lysosomal thiol
reductase
GIILTR Fwd CTATGTGCCTTGGATTGT 79 209732609
Rev CAGAGTGAAGAGTGAAGAC
15 HSP70_ONCMY Heat shock cognate 70 kDa
protein
HSP70 Fwd TCACTAGAGTCCTATGCT 85 CL7Contig1
Rev TTGTCTTGTCCTCATCAC
16 Lipopolysaccharide-induced TNF-a factor
homolog
LPSi-
TNFa
Fwd CAATTCCTTCGACCTCAT 85 209734201
Rev GCTCTTCTCCATACTGTC
17 Metalloreductase STEAP4 STEAP4 Fwd CTCCAACTCTGAAGACTATT 103 S48396453
Rev GAGCACTGTCAATCAATG
18 Myosin, heavy polypeptide 9, non-muscle Myo Fwd GCAGTTGAGACTCTACAGTGGAA 75 CB498954
Rev ACAGCGTGTTGAGTGTGGTT
19 Programmed cell death protein 2 PCDP Fwd GCATAGACAGCCACAATC 81 209735097
Rev GAGCGTAACAACCTGAAG
20 Prostaglandin E synthase 3 PGES Fwd TCCAGCCAATGTCTTAGT 99 223672934
Rev AAGCACGGTATAACTGAAC
21 P-selectin precursor P-sel Fwd CTGGTGATTCTATTGATGAC 86 209154193
Rev TTGACGCTGTAGTTGTAT
22 CD8a CD8a Fwd CGTCTACAGCTGTGCATCAATCAA 118 185135177
Rev GGCTGTGGTCATTGGTGTAGTC
23 Interleukin-12 IL-12 Fwd TCTACCTACACGACATTGTCCAGCC 62 209736091
Rev ATCCATCACCTGGCACTTCATCC
24 Prostaglandin D synthase PGDS Fwd ATCCCAGGCCGCTTCAC 59 304376917
Rev ACACGCATGTCATTTTCATTGTT
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Page 14 of 17according to the Verso™ 1-step QRT-PCR low ROX kit
(Thermo Scientific). PCR reaction mix containing 1-step
qPCR low ROX mix (2 ×), enzyme mix, RT enhancer,
900 nM of each primer, 200 nM of TaqMan probe was
mixed with 2 μl (50-100 ng) of RNA in a final volume
of 12.5 μl. This is followed by thermal cycling steps of
cDNA synthesis at 50°C for 15 min, an enzyme activa-
tion step of 95°C for 15 min, and 45 cycles of 95°C for
15 sec (denaturation) and 60°C for 60 sec (annealing/
extension). All samples were run in duplicates (or tri-
plicates) with non-template controls and non-reverse
transcription controls on the same plate. Amplification
of genomic DNA was checked by a melting curve ana-
lysis, which resulted in a single peak, indicating single
product amplification. Elongation factor 1 alpha
(EF1A) was used as an internal reference gene, as it
has been shown to be the best reference gene for RT-
qPCR studies in Atlantic salmon tissues [60]. We also
have recent experience with samples similar to those
analysed in this study and EF1A has shown an
appropriate stability [53]. This transcript has also been
represented in the microarray and did not show
response to lice. To calculate ΔCt, the respective refer-
ence Ct values were subtracted from target Ct values
of the control and test samples; and -ΔΔCt was calcu-
lated as: -ΔΔCt = - (ΔCtTest - ΔCtControl). PCR efficien-
cies were in acceptable range (Additional file 2).
Statistical analysis of the RT-qPCR data was done
using Microsoft excel and SigmaPlot 11.0. The data
were presented as mean -ΔΔCt ± SE. Differences
between control and test at each sampling point were
assessed with Student’st - t e s t .
Additional material
Additional file 1: Differentially expressed genes, complete
microarray results.
Additional file 2: Complete RT-qPCR results and PCR efficiencies.
Additional file 3: Proteases with differential expression in spleen,
microarray results.
Table 2 Primer/ probe list (Continued)
Probe TTCACCAGCCAGCGTT
25 Matrix metalloproteinase-13 MMP13 Fwd GCCAGCGGAGCAGGAA 56 213514499
Rev AGTCACCTGGAGGCCAAAGA
Probe TCAGCGAGATGCAAAG
26 T-cell receptor alpha TCRa Fwd GACAGCTACTACAGCCAGGTT 209736003
Rev CAGAATGGTCAGGGATAGGAAGTT
Probe ACACAGATGCAAAGATC
27 CD3ε CD3ε Fwd TCAGGGCTCGGAAGAAGTCT 68 185135943
Rev GCCACGGCCTGCTGA
Probe CCAAAAACCCACTTCCC
28 CD4-like protein, variant 1 CD4-1 Fwd GAATCTGCCGCTGCAAAGAC 75 185135736
Rev AGGGATTCCGGTCTGTATGATATCT
Probe CCCAAACCAAAAGGATTC
29 CD8b CD8b Fwd GGAGGCCAGGAGTTCTTCTC 70 185135192
Rev GGCTTGGGCTTCGTGACA
Probe ACCCGGAGAAACTC
30 MHC class I antigen MHC-I Fwd CAACGCCACAGGCAGTCA 64 25573077
Rev CGGTACTCATTCTGAGCTGTGTTAC
Probe CACCAAACTCAAGTGGG
31 MHC class II antigen MHC-II Fwd CTCACTGAGCCCATGGTGTAT 117 223672978
Rev GAGTCCTGCCAAGGCTAAGATG
Probe CTGGGACCCGTCCCTG
32 Immunoglobulin mu IgM Fwd TGAGGAGAACTGTGGGCTACACT 69 2182101
Rev TGTTAATGACCACTGAATGTGCAT
Probe CATCAGATGCAGGTCC
33 Immunoglobulin tau IgT Fwd CAACACTGACTGGAACAACAAGGT 97 260766539
Rev CGTCAGCGGTTCTGTTTTGGA
Probe AGTACAGCTGTGTGGTGCA
34 Elongation factor 1A EF1A Fwd CCCCTCCAGGACGTTTACAAA 57 224587629
Rev CACACGGCCCACAGGTACA
Probe ATCGGTGGTATTGGAAC
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Page 15 of 17Additional file 4: Secretory proteins, components of complement
and coagulation cascade differential expression in spleen,
microarray results.
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